Browse

Pyrithione-zinc Prevents UVB-induced Epidermal Hyperplasia by Inducing HIF-1 alpha

DC Field Value Language
dc.contributor.authorCho, Young-Suk-
dc.contributor.authorLee, Kyung-Hoon-
dc.contributor.authorPark, Jong-Wan-
dc.date.accessioned2012-07-02T05:05:45Z-
dc.date.available2012-07-02T05:05:45Z-
dc.date.issued2010-04-
dc.identifier.citationKOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY; Vol.14 2; 91-97ko_KR
dc.identifier.issn1226-4512-
dc.identifier.urihttp://hdl.handle.net/10371/78076-
dc.description.abstractEpidermal keratinocytes overgrow in response to ultraviolet-B (UVB), which may be associated with skin photoaging and cancer development. Recently, we found that HIF-1 alpha controls the keratinocyte cell cycle and thereby contributes to epidermal homeostasis. A further study demonstrated that HIF-1 alpha is down-regulated by UVB and that this process is involved in UVB-induced skin hyperplasia. Therefore, we hypothesized that the forced expression of HIF-1 alpha in keratinocytes would prevent UVB-induced keratinocyte overgrowth. Among several agents known to induce HIF-1 alpha, pyrithione-zinc (Py-Zn) overcame the UVB suppression of HIF-1 alpha in cultured keratinocytes. Mechanistically, Py-Zn blocked the degradation of HIF-1 alpha protein in keratinocytes, while it did not affect the synthesis of HIF-1 alpha. Moreover, the p21 cell cycle inhibitor was down-regulated after UVB exposure, but was robustly induced by Py-Zn. In mice repeatedly irradiated with UVB, the epidermis became hyperplastic and HIF-1 alpha disappeared from nuclei of epidermal keratinocytes. However, a cream containing Py-Zn effectively prevented the skin thickening and up-regulated HIF-1 alpha to the normal level. These results suggest that Py-Zn is a potential agent to prevent UVB-induced photoaging and skin cancer development. This work also provides insight into a molecular target for treatment of UVB-induced skin diseases.ko_KR
dc.language.isoenko_KR
dc.publisherKOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGYko_KR
dc.subjectUltravioletko_KR
dc.subjectSkinko_KR
dc.subjectPyrithione-zincko_KR
dc.subjectHypoxia-inducible factor-1 alphako_KR
dc.subjectHyperplasiako_KR
dc.titlePyrithione-zinc Prevents UVB-induced Epidermal Hyperplasia by Inducing HIF-1 alphako_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor조영석-
dc.contributor.AlternativeAuthor이경훈-
dc.contributor.AlternativeAuthor박종완-
dc.identifier.doi10.4196/kjpp.2010.14.2.91-
dc.citation.journaltitleKOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY-
dc.description.citedreferenceLuo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577-
dc.description.citedreferenceCho YS, 2009, MOL CELLS, V28, P537, DOI 10.1007/s10059-009-0148-2-
dc.description.citedreferenceCho H, 2008, MOL PHARMACOL, V74, P70, DOI 10.1124/mol.107.040162-
dc.description.citedreferenceMarrot L, 2008, J AM ACAD DERMATOL, V58, pS139, DOI 10.1016/j.jaad.2007.12.007-
dc.description.citedreferenceCho YS, 2008, BBA-MOL CELL RES, V1783, P323, DOI 10.1016/j.bbamcr.2007.11.017-
dc.description.citedreferencePark SE, 2007, PROSTATE, V67, P1514, DOI 10.1002/pros.20641-
dc.description.citedreferenceWeinreb O, 2007, FREE RADICAL BIO MED, V43, P546, DOI 10.1016/j.freeradbiomed.2007.05.011-
dc.description.citedreferenceLim JH, 2006, MOL PHARMACOL, V70, P1856, DOI 10.1124/mol.106.028076-
dc.description.citedreferenceEl-Abaseri TB, 2006, CARCINOGENESIS, V27, P225, DOI 10.1093/carcin/bgi220-
dc.description.citedreferenceMelnikova VO, 2005, MUTAT RES-FUND MOL M, V571, P91, DOI 10.1016/j.mrfmmm.2004.11.015-
dc.description.citedreferenceGuthery E, 2005, AM J INFECT CONTROL, V33, P15, DOI 10.1016/j.ajic.2004.07.012-
dc.description.citedreferenceKoshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196-
dc.description.citedreferenceSchofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366-
dc.description.citedreferenceLee JK, 2003, J DERMATOL SCI, V32, P171, DOI 10.1016/S0923-1811(03)00094-X-
dc.description.citedreferenceBAILEY P, 2003, INT J COSMETIC SCI, V25, P183-
dc.description.citedreferencePierard-Franchimont C, 2002, SKIN PHARMACOL APPL, V15, P434, DOI 10.1159/000066452-
dc.description.citedreferenceHudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002-
dc.description.citedreferenceIsaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200-
dc.description.citedreferenceLang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017-
dc.description.citedreferenceArsham AM, 2002, J BIOL CHEM, V277, P15162, DOI 10.1074/jbc.M111162200-
dc.description.citedreferenceChun YS, 2000, BIOCHEM BIOPH RES CO, V268, P652-
dc.description.citedreferenceOuhtit A, 2000, AM J PATHOL, V156, P201-
dc.description.citedreferenceHuang LE, 1998, P NATL ACAD SCI USA, V95, P7987-
dc.description.citedreferenceIyer NV, 1998, GENE DEV, V12, P149-
dc.description.citedreferenceWANG GL, 1995, J BIOL CHEM, V270, P1230-
dc.description.tc3-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Pharmacology (약리학전공)Journal Papers (저널논문_약리학전공)
Files in This Item:
There are no files associated with this item.
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse